• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge.产生物膜的多重耐药鲍曼不动杆菌:一个新出现的挑战。
J Clin Diagn Res. 2015 Jan;9(1):DC08-10. doi: 10.7860/JCDR/2015/11014.5398. Epub 2015 Jan 1.
2
[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].[耐碳青霉烯类鲍曼不动杆菌的耐药机制及体外联合用药的应用]
Zhonghua Shao Shang Za Zhi. 2014 Apr;30(2):166-70.
3
Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii.鲍曼不动杆菌耐亚胺培南临床分离株中生物膜形成与多重耐药性之间的相关性
Indian J Med Microbiol. 2008 Oct-Dec;26(4):333-7. doi: 10.4103/0255-0857.43566.
4
[Correlation between the biofilm-forming ability, biofilm-related genes and antimicrobial resistance of Acinetobacter baumannii].鲍曼不动杆菌生物膜形成能力、生物膜相关基因与抗菌药物耐药性之间的相关性
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Sep;26(9):639-43. doi: 10.3760/cma.j.issn.2095-4352.2014.09.007.
5
[Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].[从临床样本中分离的鲍曼不动杆菌菌株中β-内酰胺酶相关耐药性的分子特征分析]
Mikrobiyol Bul. 2014 Jul;48(3):365-76.
6
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.台湾地区鲍曼不动杆菌临床分离株对环丙沙星、氨苄西林/舒巴坦和亚胺培南耐药机制的研究。
Int J Antimicrob Agents. 2010 Apr;35(4):382-6. doi: 10.1016/j.ijantimicag.2009.12.009. Epub 2010 Feb 6.
7
Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study.中国东部多药耐药鲍曼不动杆菌中整合子的流行情况及特征:一项多医院研究
Int J Environ Res Public Health. 2015 Aug 21;12(8):10093-105. doi: 10.3390/ijerph120810093.
8
[Antimicrobial susceptibility and molecular characterization of multidrug-resistant Acinetobacter baumannii isolated in an university hospital].[某大学医院分离的多重耐药鲍曼不动杆菌的药敏性及分子特征]
Mikrobiyol Bul. 2016 Oct;50(4):522-534. doi: 10.5578/mb.34158.
9
A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.一项关于重症监护病房中具有临床和环境特征的多重耐药鲍曼不动杆菌感染的抗菌药物耐药性评估和分子流行病学的前瞻性多中心研究。
Ann Clin Microbiol Antimicrob. 2019 Jul 2;18(1):19. doi: 10.1186/s12941-019-0319-8.
10
A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.希腊一家三级医院鲍曼不动杆菌临床分离株耐药性的5年监测研究
Infect Chemother. 2016 Sep;48(3):190-198. doi: 10.3947/ic.2016.48.3.190. Epub 2016 Sep 9.

引用本文的文献

1
High Prevalence of Virulence and Genes Encoding Carbapenemases Among Isolates from Hospitalised Patients in Three Regions of Poland.波兰三个地区住院患者分离株中耐药性及碳青霉烯酶编码基因的高流行率
Pathogens. 2025 Jul 24;14(8):731. doi: 10.3390/pathogens14080731.
2
Biofilm Production in Intensive Care Units: Challenges and Implications.重症监护病房中的生物膜形成:挑战与影响
Pathogens. 2024 Nov 1;13(11):954. doi: 10.3390/pathogens13110954.
3
Identification of determinants that allow maintenance of high-level fluoroquinolone resistance in .确定在……中维持高水平氟喹诺酮耐药性的决定因素。 (注:原文句子不完整,缺少具体描述的主体)
mBio. 2025 Jan 8;16(1):e0322124. doi: 10.1128/mbio.03221-24. Epub 2024 Nov 26.
4
Identification of Determinants that Allow Maintenance of High-Level Fluoroquinolone Resistance in .鉴定允许在……中维持高水平氟喹诺酮耐药性的决定因素 。 (原文句子不完整,翻译可能存在局限性)
bioRxiv. 2024 Oct 16:2023.10.03.560562. doi: 10.1101/2023.10.03.560562.
5
Analysis of carbapenem-resistant carbapenemase gene distribution and biofilm formation.耐碳青霉烯类碳青霉烯酶基因分布及生物膜形成分析
Int J Mol Epidemiol Genet. 2024 Feb 15;15(1):1-11. doi: 10.62347/KBSB9946. eCollection 2024.
6
Prevalence of biofilm producing Acinetobacter baumannii clinical isolates: A systematic review and meta-analysis.生物膜产生鲍曼不动杆菌临床分离株的流行率:系统评价和荟萃分析。
PLoS One. 2023 Nov 30;18(11):e0287211. doi: 10.1371/journal.pone.0287211. eCollection 2023.
7
Acinetobacter baumannii in suspected bacterial infections: Association between multidrug resistance, virulence genes, & biofilm production.鲍曼不动杆菌在疑似细菌性感染中的研究:多重耐药性、毒力基因与生物膜生成之间的关系。
Indian J Med Res. 2023 Oct 1;158(4):439-446. doi: 10.4103/ijmr.ijmr_3470_21. Epub 2023 Sep 25.
8
Extensive Drug Resistance of Strong Biofilm-Producing Strains Isolated from Infections and Colonization Hospitalized Patients in Southern Poland.从波兰南部住院患者感染和定植中分离出的具有强大生物膜形成能力菌株的广泛耐药性
Pathogens. 2023 Jul 26;12(8):975. doi: 10.3390/pathogens12080975.
9
Acinetobacter Baumannii Phages: Past, Present and Future.鲍曼不动杆菌噬菌体:过去、现在和未来。
Viruses. 2023 Mar 3;15(3):673. doi: 10.3390/v15030673.
10
Multidrug-Resistant Acinetobacter: Detection of ESBL, MBL, Genotype, and Biofilm Formation at a Tertiary Care Hospital in Eastern Nepal.多重耐药不动杆菌:尼泊尔东部一家三级护理医院中ESBL、MBL、基因型及生物膜形成的检测
Int J Microbiol. 2022 Dec 10;2022:8168000. doi: 10.1155/2022/8168000. eCollection 2022.

本文引用的文献

1
[Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].[多重耐药鲍曼不动杆菌分离株毒力因子的研究]
Mikrobiyol Bul. 2014 Jan;48(1):70-81.
2
Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit.重症监护病房鲍曼不动杆菌和铜绿假单胞菌临床分离株中生物膜形成与多重耐药性的关联
Indian J Crit Care Med. 2013 Jul;17(4):214-8. doi: 10.4103/0972-5229.118416.
3
Molecular epidemiology of aminoglycosides resistance in acinetobacter spp. With emergence of multidrug-resistant strains.不动杆菌属中氨基糖苷类耐药的分子流行病学。随着多重耐药菌株的出现。
Iran J Public Health. 2010;39(2):63-8. Epub 2010 Jun 30.
4
In silico analysis of antibody triggering biofilm associated protein in Acinetobacter baumannii.鲍曼不动杆菌抗体触发生物膜相关蛋白的计算机分析。
J Theor Biol. 2010 Sep 21;266(2):275-90. doi: 10.1016/j.jtbi.2010.06.014. Epub 2010 Jun 23.
5
Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii.鲍曼不动杆菌耐亚胺培南临床分离株中生物膜形成与多重耐药性之间的相关性
Indian J Med Microbiol. 2008 Oct-Dec;26(4):333-7. doi: 10.4103/0255-0857.43566.
6
Acinetobacter baumannii: emergence of a successful pathogen.鲍曼不动杆菌:一种成功病原体的出现
Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07.
7
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications.鲍曼不动杆菌生物膜形成:相关特征及临床意义
Clin Microbiol Infect. 2008 Mar;14(3):276-8. doi: 10.1111/j.1469-0691.2007.01916.x. Epub 2008 Jan 10.
8
Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.鲍曼不动杆菌多重耐药临床分离株形成生物膜并黏附于上皮细胞表面的能力。
Clin Microbiol Infect. 2008 Jan;14(1):49-54. doi: 10.1111/j.1469-0691.2007.01842.x. Epub 2007 Nov 13.
9
Clinical impact and pathogenicity of Acinetobacter.不动杆菌的临床影响及致病性
Clin Microbiol Infect. 2005 Nov;11(11):868-73. doi: 10.1111/j.1469-0691.2005.01227.x.
10
Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.1998年至2001年美国住院患者铜绿假单胞菌和鲍曼不动杆菌临床分离株的抗菌药物敏感性监测。
Antimicrob Agents Chemother. 2003 May;47(5):1681-8. doi: 10.1128/AAC.47.5.1681-1688.2003.

产生物膜的多重耐药鲍曼不动杆菌:一个新出现的挑战。

Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge.

作者信息

Badave Gitanjali Kailas, Kulkarni Dhananjay

机构信息

Assistant Professor, Department of Microbiology, Konaseema Institute of Medical Science & Research Foundation , Amalapuram, Andhra Pradesh, India .

Assistant Professor, Department of Pharmacology, Konaseema Institute of Medical Science & Research Foundation , Amalapuram, Andhra Pradesh, India .

出版信息

J Clin Diagn Res. 2015 Jan;9(1):DC08-10. doi: 10.7860/JCDR/2015/11014.5398. Epub 2015 Jan 1.

DOI:10.7860/JCDR/2015/11014.5398
PMID:25737985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4347076/
Abstract

AIM

To study the quantitative method for biofilm formation and examine the correlation between biofilm formation and antibiotic resistance among the clinical isolates of Acinetobacter baumannii.

MATERIALS AND METHODS

A total of 72 A. baumannii isolates from different clinical specimens were processed and confirmed by conventional microbiological methods. Antimicrobial susceptibility testing was performed by Kirby Bauer disc diffusion method using six antibiotics. Biofilm formation was studied by microtitre plate assay.

RESULTS

Forty five (62.5%) of 72 isolates produced biofilm. Resistance to ampicillin-sulbactam was least. 36.1% isolates were resistant to imipenem, 66.6% to ceftazidime, 72.2% to ciprofloxacin, 80.5% to amikacin and 84.7% to piperacillin. Biofilm formers showed greater resistance to ampicillin- sulbactam, amikacin, ciprofloxacin and ceftazidime as compared to imipenem and piperacillin. In all 65 (90.3%) isolates showed multiple drug resistance. Correlation between multidrug resistance and biofilm formation was analysed statistically and p-value was found to be significant (p-value =0.0004; p-value < 0.05 is significant by Chi - Square Test).

CONCLUSION

The study concludes that there a positive correlation between biofilm formation and multiple drug resistance in A. baumannii.

摘要

目的

研究鲍曼不动杆菌临床分离株生物膜形成的定量方法,并检测生物膜形成与抗生素耐药性之间的相关性。

材料与方法

对从不同临床标本中分离出的72株鲍曼不动杆菌进行处理,并采用传统微生物学方法进行鉴定。使用六种抗生素,通过 Kirby Bauer 纸片扩散法进行药敏试验。采用微量滴定板法研究生物膜形成情况。

结果

72株分离株中有45株(62.5%)形成生物膜。对氨苄西林 - 舒巴坦的耐药率最低。36.1%的分离株对亚胺培南耐药,66.6%对头孢他啶耐药,72.2%对环丙沙星耐药,80.5%对阿米卡星耐药,84.7%对哌拉西林耐药。与亚胺培南和哌拉西林相比,生物膜形成菌对氨苄西林 - 舒巴坦、阿米卡星、环丙沙星和头孢他啶表现出更高的耐药性。所有分离株中,65株(90.3%)表现出多重耐药性。对多重耐药性与生物膜形成之间的相关性进行统计学分析,发现p值具有显著性(p值 = 0.0004;卡方检验中p值 < 0.05具有显著性)。

结论

该研究得出结论,鲍曼不动杆菌生物膜形成与多重耐药性之间存在正相关。